Editorial
The lung: a magnificent organ that needs lifelong attention
The next Director-General of WHO
Transforming primary care
Comment
Vilanterol fluticasone and mortality in comorbid COPD GOLD B
Not another steroid trial: early low-dose hydrocortisone in preterm infants
PD-L1 in non-small-cell lung cancer: the third target for immunotherapy
Firearm legislation and mortality in the USA
Expanding the benefits of HPV vaccination to boys and men
World Report
US responds to increase in Zika cases
The age of drones: what might it mean for health?
Perspectives
The ship of hope
Designs upon death in ancient Egypt
Maria Neira: no limits to public health
The medicine of Alex Higgins
Correspondence
No universal health coverage without primary health care
Positive IgM for Zika virus in the cerebrospinal fluid of 30 neonates with microcephaly in Brazil
Zika virus and hyperglycaemia in pregnancy
Uncommon presentation of Zika fever or co-infection?
The urgency of a sociocultural approach to adolescent men's health risk behaviours
Articles
Fluticasone furoate and vilanterol and survival in chronic obstructive pulmonary disease with heightened cardiovascular risk (SUMMIT): a double-blind randomised controlled trial
Effect of early low-dose hydrocortisone on survival without bronchopulmonary dysplasia in extremely preterm infants (PREMILOC): a double-blind, placebo-controlled, multicentre, randomised trial
Atezolizumab versus docetaxel for patients with previously treated non-small-cell lung cancer (POPLAR): a multicentre, open-label, phase 2 randomised controlled trial